جزییات کتاب
Meeting the needs of patients while minimizing blood transfusions requires special expertise, precise monitoring and innovative techniques. This cutting-edge resource covers all the important clinical aspects of transfusion medicine in diverse clinical settings, with a special emphasis on alternatives to transfusion. Edited by a multidisciplinary team consisting of a transfusion specialist, an anesthesiologist and an intensive care specialist this book is endorsed by the Network for Advancement of Transfusion Alternatives. The contributors review the appropriate use of fluids and of blood products, and describe the latest treatment options available to decrease the need for allogeneic blood products including: Argon beam Cell saver Harmonic scalpel Normovolemic haemodilution Synthetic erythropoietin Antifibrinolytics Recombinant factor VIIa Advanced monitoring of hemostasis Intravenous iron The new edition is a key reference source for all those involved in the practice of blood management and conservation.Content: Chapter 1 From Blood Transfusion to Transfusion Medicine (pages 1–8): Alice ManiatisChapter 2 Allogeneic Blood Components (pages 9–20): Rebecca Cardigan and Sheila MaclennanChapter 3 Current Information on the Infectious Risks of Allogeneic Blood Transfusion (pages 21–30): Alan D. Kitchen and John A. J. BarbaraChapter 4 Immunological Complications of Blood Transfusion (pages 31–46): Clare Taylor, Cristina Navarrete and Marcela ContrerasChapter 5 Immunomodulation and Allogeneic Blood Transfusion (pages 47–59): Marloes Waanders, Leo Van De Watering and Anneke BrandChapter 6 Pathogen Inactivation of Blood Components (pages 60–67): Chris ProwseChapter 7 The Benefits of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have? (pages 68–81): Neil Soni and Benjamin ThomasChapter 8 Plasma and Albumin (pages 83–108): Philippe L. BaeleChapter 9 Pharmacology of Intravenous Fluids (pages 109–118): Michael F. M. JamesChapter 10 Crystalloids versus Colloids: The Controversy (pages 119–136): Hengo HaljamaeChapter 11 Effects of Synthetic Colloids on Hemostasis (pages 137–149): Sibylle A. Kozek?langenecker and Gisela ScharbertChapter 12 Hydroxyethyl Starch and Renal Dysfunction (pages 150–157): Laurent Jacob, Nicholas Heming and Bertrand GuidetChapter 13 Choice of a Synthetic Colloid for Surgery (pages 158–167): Joachim BoldtChapter 14 Choice of Colloid for Intensive Care Patients (pages 168–178): Yasser Sakr and Yalcin InelChapter 15 Hypertonic Saline Solutions for the Initial Treatment of Patients with Traumatic Injuries (pages 179–193): Charles E. Wade and Michael A. DubickChapter 16 Hyperchloremic Acidosis (pages 194–202): Edward Burdett and Andre VercueilChapter 17 Basic Principles of Oxygen Transport and Calculations (pages 203–209): Jean?Louis Vincent, Pongdhep Theerawit and Davide SimionChapter 18 Assessment of Tissue Oxygenation (pages 210–217): Michael Piagnerelli, Ann Dierick and Philippe Van der LindenChapter 19 Tissue Oxygenation and Blood Transfusion (pages 218–228): Stefan Suttner and Joachim BoldtChapter 20 Anemia and Cardiovascular Disease (pages 229–251): Antonis S. Manolis, Spyridon Koulouris, Kostas Triantafyllou, Dimitris Sakellariou, Sokratis Pastromas and Helen MelitaChapter 21 Monitoring of Hemostasis in the Perioperative Setting (pages 253–266): Sibylle A. Kozek?Langenecker and Eva SchadenChapter 22 Antifibrinolytics in Open?Heart Surgery (pages 267–277): Wulf DietrichChapter 23 Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients (pages 278–292): Jean?francois Hardy, Sylvain Belisle and Philippe Van der LindenChapter 24 Role of Hemoglobin/Hematocrit (pages 293–302): Kristine J. Guleserian, Hae W. Kim, Bruce Pearce, Arkadiy Pitman and A. Gerson GreenburgChapter 25 Calculation of Blood Loss (pages 303–312): Mark E. BrecherChapter 26 Management of Massive Transfusion (pages 313–328): Jean?Francois Hardy and Marc SamamaChapter 27 Iron Deficiency: Causes, Diagnosis, and Management (pages 329–347): Manuel Munoz, Jose Antonio Garcia?Erce and Elvira BisbeChapter 28 Current Status of Perisurgical Erythropoietin Therapy (pages 348–356): Lawrence T. GoodnoughChapter 29 Erythropoietin and Iron Therapy in Patients with Renal Failure (pages 357–367): Lucia Del Vecchio and Francesco LocatelliChapter 30 Hemoglobin?based Blood Substitutes (pages 368–379): G. Deby?Dupont, Bernadette Remy and Maurice LamyChapter 31 Perfluorocarbon Emulsions (pages 380–388): Pedro CabralesChapter 32 Minimally Invasive Cardiac Surgery: Impact on Blood Loss and Transfusion (pages 390–407): He Tao and Fraser RubensChapter 33 Adjunctive Strategies to Impact Blood Transfusion in Cardiac Surgery (pages 408–417): L. Ressler and Fraser RubensChapter 34 Anesthetic Techniques to Reduce Blood Loss (pages 420–429): Dafydd ThomasChapter 35 Controlled Hypotension Decreases Blood Transfusion Requirement: Fact or Fallacy? (pages 430–438): Richard P. DuttonChapter 36 Acute Normovolemic Hemodilution (pages 439–449): Javad Bidgoli and Philippe Van der LindenChapter 37 Hyperoxic Hemodilution (pages 450–457): Jens Meier, Konrad Messmer and Oliver HablerChapter 38 Intraoperative and Postoperative Cell Salvage (pages 458–474): Ernil Hansen and Hans GombotzChapter 39 Anemia and Red Blood Transfusion in Critical Care (pages 476–489): Tim WalshChapter 40 Red Blood Cell Transfusions and Alternatives to Treat the Anemia of Prematurity (pages 490–497): Ronald G. StraussChapter 41 Transfusion Alternatives in Orthopedic Surgery (pages 498–508): Manuel Munoz, Jose Antonio Garcia?Erce and Jorge CuencaChapter 42 Transfusion Alternatives in Obstetrics (pages 509–519): Christian BreymannChapter 43 Ethical Aspects of Informed Consent: American Models (pages 521–530): Ronald E. DomenChapter 44 Blood Transfusions, Jehovah's Witnesses, and the American Patients' Rights Movement (pages 531–555): Charles H. BaronChapter 45 The Cost and Cost?Effectiveness of Allogeneic and Autologous Blood (pages 557–568): Brian CusterChapter 46 Autologous Blood Predonation in Cardiac Surgery (pages 569–574): Wulf DietrichChapter 47 Cost?Effectiveness of Pharmacological Alternatives (pages 575–580): Dean Fergusson and Brian Hutton